Lunit Selected as Operator for UAE Abu Dhabi 'National Breast Cancer Screening' Program
Lunit Insight MMG to Be Used for Five Years
in Abu Dhabi National Breast Cancer Screening Program
Medical artificial intelligence (AI) company Lunit has been selected as the national breast cancer screening service provider in Abu Dhabi, United Arab Emirates (UAE).
On the 18th, Lunit announced that it signed a supply contract with SEHA, the largest healthcare service organization in the Middle East, for the AI imaging analysis solution for mammography, 'Lunit Insight MMG,' and will commence the UAE Abu Dhabi national breast cancer screening project.
Starting with Australia in 2022, Lunit has been expanding its presence in the global national cancer screening market, covering Europe including Sweden and Iceland, some Latin American countries, and Middle Eastern regions such as Saudi Arabia and Qatar. With this additional contract in the UAE, Lunit will accelerate its global B2G (business-to-government) market penetration.
SEHA, established in 2007, is the largest integrated healthcare service organization in the Middle East. It operates 14 general hospitals and 70 clinics, with over 3,000 beds and more than 2,300 physicians on staff. It is a large-scale medical institution providing world-class healthcare services. After signing a memorandum of understanding (MOU) with Lunit in October 2022, SEHA verified the performance of Lunit's AI solution at local medical institutions for about two years, leading to this contract. SEHA plans to analyze over 100,000 mammography medical images using Lunit's AI solution over the next five years.
Seobum Seok, CEO of Lunit, said, "This contract is the result of UAE medical professionals directly confirming the excellence of Lunit's AI solution through a thorough prior verification process," adding, "We will accelerate the expansion of global national cancer screening projects, using the Middle Eastern market, where medical AI adoption is accelerating, as a foothold."
Hot Picks Today
At President Lee's Call to "Give Enough to Shock," Whistleblower Rewards Become a Real Lottery
- If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Meanwhile, according to a report by global market research firm Grand View Research, the Middle Eastern medical AI market was approximately $200 million (about 289 billion KRW) as of the end of last year. It is expected to expand significantly to up to $1.5 billion (about 2.169 trillion KRW) within the next 5 to 7 years. In particular, the UAE, which has excellent medical infrastructure even within the Middle East, is recording an annual growth rate of 34.6% in the medical AI market and is expected to grow to $137.9 million (about 199 billion KRW) by 2030.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
